Company Filing History:
Years Active: 2023-2025
Title: Innovations by Inventor Roberto Bravo
Introduction
Roberto Bravo is a notable inventor based in Rheinfelden, Switzerland. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of solid dosage forms comprising antibodies. With a total of 2 patents to his name, Bravo's work is instrumental in advancing drug delivery systems.
Latest Patents
Roberto Bravo's latest patents include innovative methods for preparing solid dosage forms. The first patent, titled "Method for preparing a solid dosage form comprising antibodies by wet granulation, extrusion and spheronization," focuses on creating immediate and sustained release solid dosage forms. This method involves wet granulation, extrusion, and spheronization, with an optional delayed release coating. The solid dosage forms produced by this method are intended for topical treatment in the gastrointestinal tract of patients.
The second patent, "Preparation of solid dosage forms comprising antibodies by solution/suspension layering," describes a similar approach. This method also aims to prepare immediate and sustained release solid dosage forms using solution/suspension layering, with the possibility of a delayed release coating. These innovations are crucial for enhancing the efficacy of treatments involving antibodies.
Career Highlights
Roberto Bravo is currently associated with Tillotts Pharma AG, a company known for its focus on gastrointestinal therapies. His work at Tillotts Pharma AG has allowed him to collaborate with other experts in the field, further enriching his contributions to pharmaceutical innovations.
Collaborations
Some of his notable coworkers include Felipe Varum and Laetitia Von Rochow. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical industry.
Conclusion
Roberto Bravo's innovative approaches to solid dosage forms represent a significant advancement in pharmaceutical technology. His patents reflect a commitment to improving patient care through effective drug delivery systems.